Bupa has extended its partnership with private cancer care provider GenesisCare until August 2027.
The contract renewal will see both organisations working to expand the provision of radiotherapy and systemic therapy services for Bupa’s UK health insurance customers.
The move will also see Bupa prioritise a number of initiatives including the further development and expansion of Bupa’s Cancer Specialist Centres network.
Bupa first launched its network of specialist centres for breast cancer in 2019 but they recently expanded to include bowel and prostate cancer. Services include access to breakthrough cancer drugs and treatments often before they are available on the NHS.
Justin Hely, CEO for UK and Europe at GenesisCare, said: “We’re proud of our partnership with Bupa and look forward to further building on our key strategic priorities over the next four years.
“This includes our commitment to working together on expanding much-needed patient access to our specialist cancer care network, where we lead the way in delivering expert, personalised care and speed of access to tests, technology and treatment to aid quicker patient recovery and help save lives.”
Alex Perry, CEO for Bupa UK Insurance, (pictured) said: “We’re delighted to extend our partnership with GenesisCare to deliver fast access to cancer care for our customers.
“Cancer cases are on in the rise in the UK – it’s estimated that by 2030, around 4 million people will be living with the disease.
“It’s vital that we continue innovating with our hospital partners to deliver life-changing improvements in cancer care through the further development of our Specialist Centres network.”
